June 02, 2026 a 11:43 am
BDX: Fundamental Ratio Analysis - Becton, Dickinson and Company
Becton, Dickinson and Company, with its diversified product offerings in the medical, life sciences, and interventional sectors, remains a significant player in the healthcare industry. Despite challenges in global healthcare dynamics, BDX continues to demonstrate resilience and consistent growth due to its broad product reach and innovative solutions.
Fundamental Rating
The fundamental analysis reveals a stable financial stance, with a consistent performance in multiple financial metrics, though some areas like debt-to-equity may need attention.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 3 |
Historical Rating
The historical scoring reflects stability over time, indicating minimal variance in fundamental strengths.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | 3 | 5 | 3 | 4 | 1 | 1 | 3 |
| Previous | 0 | 5 | 3 | 4 | 1 | 1 | 3 |
Analyst Price Targets
Analyst projections indicate a moderate outlook with a consensus of 'Hold', reflecting varied opinions on future stock performance.
| High | Low | Median | Consensus |
|---|---|---|---|
| 204 | 159 | 169.03 | 174.81 |
Analyst Sentiment
The current sentiment suggests caution, with the majority of analysts recommending a 'Hold' position, supported by a diverse distribution of other ratings.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 17 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Becton, Dickinson and Company remains a strong contender in the healthcare industry with stable financial metrics and a varied product portfolio. However, challenges such as debt levels persist, affecting financial flexibility. The stock's 'Hold' consensus reflects potential growth tempered by cautionary sentiment. Investors should weigh potential growth opportunities in the healthcare sector against market risks before taking positions in BDX. Overall, the company's committed innovation and wide reach offer substantial prospects for long-term gains.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years